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Abstract
To assess the impact of systemic oxidative stress on humoral immune responses, we examined the relation
between levels of serum 8-isoprostane and serum IgG antibodies against 17 microorganisms in the commensal
oral biofilm among the ARIC population of community-dwelling adults (n¼ 4,717). Bivariately, serum 8-isoprostane
was associated with age, race=center, education, smoking, serum triglycerides, and the extent of periodontal
disease severity. Total IgG antibody directed to the oral biofilm was significantly associated with race=center,
hypertension, triglycerides, periodontal disease severity, plaque, and serum 8-isoprostane. In multivariate
models, the highest quartile of increased 8-isoprostane displayed marked reductions (44%) in biofilm IgG
antibody in contrast to small increases in total IgG antibody level for the highest quartiles of oral bacterial
burden or periodontal disease severity (19 and 12%, respectively; p< 0.0001). Increased 8-isoprostane was as-
sociated with decreased total IgG antibody ( p< 0.0001) in subjects with or without extensive periodontal disease
and=or biofilm and with suppression of IgG responses across the entire biofilm composition. Increased systemic
oxidative stress is associated with a generalized decrease of serum IgG antibody responses to the oral biofilm.
Levels of oral microbial burden, periodontitis severity, and smoking are, by comparison, minor modifiers of
serum IgG responses to the commensal oral biofilm. Antioxid. Redox Signal. 11, 2973–2983.
Introduction
Oxidative stress is an important physiologic modifierof immune (48) and inflammatory mechanisms (36).
Mediators of oxidative stress or ‘‘redox signaling’’ or both
have been shown to regulate receptor (11) and transcription
factor signaling (48) and to induce NF-kB (31) and kinase-
dependent signaling pathways (50), thereby inducing the
expression of key cytokines (26) and inflammatory mediators.
Oxidative stress can shift the balance of Th1 and Th2 cytokine
profiles in in vitro (52) and in vivo model systems (47 and 53),
typically toward a Th2 cytokine profile, suggesting that oxi-
dative stress might modify humoral immune responses to
commensal and pathogenic microorganisms. Clinical condi-
tions associated with increased oxidative stress in humans
[e.g., smoking (56), diabetes (23), periodontitis (12), and aging
(42)] have been associated with impaired immune function
(44). Smoking, a recognized risk factor for periodontitis (7),
has been associated with depressed levels of total serum IgG2
(55), which is a Th1-dependent IgG antibody subtype, and
with decreased serum levels of antibody for selected oral
bacteria (60). Diabetes has been associated with changes in
T-cell populations and decreased IgG antibody responses to
oral bacteria (20). Aging has been associated with a decreased
antibody response to vaccination (21). In some reports, ther-
apies designed to reduce oxidative stress have been related to
improved outcomes in viral infections and improved cell-
mediated immune function in animal models and human
clinical trials (10, 26, 36, 43). Thus, it is of interest to deter-
mine the association of systemic levels of oxidative stress with
serum levels of IgG antibody to commensal and pathogenic
microorganisms within a clinical population.
Mucosal surfaces retain a complex and diverse community
of microorganisms that exist as a biofilm lining the oral cavity,
the gut, the respiratory, and the reproductive tracts. Many of
these organisms are commensal but can cause disease when a
breach in mucosal integrity occurs. The humoral antibody
response (e.g., serum IgG) to organisms within the mucosal
environment is generally of low concentration as a minor
immunoglobulin component of mucosal secretions, but it can
play an important role when a loss of mucosal epithelial in-
tegrity occurs in conditions such as gingivitis, periodontitis,
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ulcerative colitis, cystic fibrosis, and other conditions that
cause inflammation or ulceration, or both, of mucosal sur-
faces. Most of these clinical conditions tend to be associated
with increases in serum antibody titers to specific organisms
within the biofilm, presumably as a consequence of bacterial
presentation via tissue invasion or penetration of the organ-
ism, or components such as LPS. These systemic antibodies
presumably also have a role in clearing bacteremias (1, 3)
associated with systemic exposure to the oral microbes, a
possible risk factor for systemic diseases (5, 6).
It was our general hypothesis that systemic oxidative stress,
as measured by increasing serum levels of 8-isoprostane,
would be a significant negative modifier of the serum-antibody
responses to mucosal biofilm microorganisms. Specifically, we
hypothesized that increased oxidative stress would be associ-
ated with suppression of the systemic IgG antibody responses
to the indigenous oral biofilm microorganisms. To test this
hypothesis, we examined the relations between serum levels of
8-isoprostane and serum levels of IgG antibodies against a
panel of 17 microorganisms indigenous to the oral subgingival
biofilm in a large sample of community-dwelling adults, con-




The Atherosclerosis Risk in Communities (ARIC) study
(27) is a prospective investigation supported by the National
Heart Lung and Blood Institute (NHLBI) of community
dwellers to characterize the natural history of atherosclerosis
and of clinical cardiovascular disease in four U.S. communi-
ties ( Jackson, Mississippi; Washington County, Maryland;
suburban Minneapolis, Minnesota; and Forsyth County,
North Carolina). The Jackson cohort comprised entirely
African-Americans. A sample of 15,792 community-dwelling
residents aged 45–64 years at baseline took part in an evalu-
ation of cardiovascular risk factors and their sequelae. The
Dental ARIC, an ancillary study funded by the National In-
stitute of Dental and Craniofacial Research (NIDCR), was
conducted during ARIC visit 4 in 1996 through 1998 and is
cross-sectional in design. The Dental ARIC consisted of an
oral examination, collection of serum, and interviews. Persons
requiring antibiotic prophylaxis for periodontal probing were
excluded. The Dental ARIC study was conducted among a
diverse population of middle-aged adults and includes mea-
sures of a serum marker of oxidative stress (8-isoprostane),
measures of the levels of a panel of serum antibodies to oral
bacteria, and clinical measures of total oral microbial load (i.e.,
plaque) and extent of periodontal disease. No exclusion cri-
teria were used except for total edentulism and the need for
antibiotic prophylaxis for the dental examination. Also, data
were collected about factors known to contribute to oxidative
stress (e.g., smoking and diabetes). The protocols for this
clinical investigation were reviewed and approved by the
Institutional Review Boards of the respective institutions.
Exposure variables
Clinical measures included probing depth (PD) and
cementoenamel-junction measures relative to the gingival
margin (CEJ) on six sites for all teeth. Clinical attachment level
(CAL) was calculated from the sum of PD and CEJ scores. Oral
plaque was measured by using the Plaque Index (PI) (40). Loe
Gingival Index and Bleeding on Probing were also measured.
Periodontal examiners at the ARIC centers were calibrated to
a standard examiner, and the range for weighted kappas was
0.86 to 0.94. Intraclass coefficients ranged from 0.87 to 0.95.
Percentage of agreement within 1 mm ranged from 88.9 to
94.9%. We chose to focus our analysis by using probing
depths as a measure of periodontal status, and plaque, as a
measure of microbial exposure. Among the clinical signs, PD
was the single best predictor of serum IgG antibody levels. To
create quartiles of extent scores, participants were ranked on
the percentage of sites with PD 5 mm or more or percentage of
sites with PI scores of 1 or more. Participants in the top
quartile of number of sites with PD of 5 mm or more or PI
scores of 1 or more were considered ‘‘High.’’ The participants
in the remaining three quartiles of either PD>5 mm or PI were
considered ‘‘Low.’’
Serum 8-isoprostane
Direct-8-iso-Prostaglandin F2a (d-8-iso PGF2a) is a stable
end product of both specific inflammatory enzymatic path-
ways and nonspecific mechanisms and reflects total lipid
peroxidation, representing an excellent in vivo marker for
oxidative stress (56). The d-8-iso PGF2a assay is based on the
competition between sample 8-iso-PGF2a and a fixed amount
of alkaline phosphatase (AP)-labeled 8-iso-PGF2a for sites on
a rabbit polyclonal anti-8-iso-PGF2a (Assay Designs, Ann
Arbor, MI). During the incubation, the polyclonal antibody
becomes bound to the goat anti-rabbit antibody coated onto
the microplate. After a wash to remove excess conjugate and
unbound sample, a substrate solution is added to the wells to
determine the bound enzyme activity. Color development is
stopped, and absorbance read at 405 nm. The intensity of the
color is proportional to the amount of AP-PGF2a bound to the
well, which is inversely proportional to the concentration of
total 8-iso-PGF2a originally present in the sample. Standard
curves ranged from 100 ng=ml to 32 pg=ml, and serum sam-
ples were diluted 1:5 to yield values within the working
range. Deviations of standard duplicates ranged from 1.0 to
18.8%, with a mean deviation of 5.9%. Sensitivity limit of
detection was estimated by the manufacturer as 103.2 pg=ml
for the 2-h incubation format. Participants were ranked on the
serum concentration of d-8-iso PGF2a. With this ranking,
participants in the top quartile of concentration of d-8-iso
PGF2a were considered ‘‘High.’’ The participants in the re-
maining three quartiles of concentration of d-8-iso PGF2a were
considered ‘‘Low.’’
Outcome variables
The main outcome variables were serum IgG antibody
levels of 17 selected periodontal organisms [Porphyromonas
gingivalis; Prevotella intermedia; Prevotella nigrescens; Tannerella
forsythensis; Treponema denticola; Fusobacterium nucleatum;
Aggregatibacter actinomycetemcomitans; Campylobacter rectus;
Eikenella corrodens; Parvimonas micra; Veillonella parvula; Cap-
nocytophaga ochracea; Seleomonas noxia; Actinomyces viscosus;
Streptococcus intermedius; Streptococcus sanguis; and Strepto-
coccus oralis]. Serum samples collected as part of the ARIC
examination were divided into aliquots at each examination
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site, frozen at808C, transported on dry ice to our laboratory,
and stored in aliquots at808C. Samples were assayed for IgG
antibody levels directed against the aforementioned 17 peri-
odontal organisms by using the checkerboard immunoblot-
ting technique described by Sakellari et al. (57). This assay
permits rapid quantification of serum antibody levels against
a wide range of bacterial species in multiple serum samples
simultaneously. In brief, bacterial antigens from each species
and protein A from Staphylococcus aureus (Sigma, St. Louis,
MO) were deposited in parallel lanes on nitrocellulose mem-
branes (Hybond ECL; Amersham, Arlington Heights, IL), by
using a Miniblotter device (Immunetics, Cambridge, MA).
Whole bacterial suspensions, sonicated for 10 s and adjusted
at an optical density of 1.0 (wavelength, 600 nm) were used as
bacterial antigens. Subjects’ serum samples in 1:500 dilution,
as well as serial dilutions of human IgG immunoglobulin
(100, 200, and 400 ng=ml; Sigma), were deposited in lanes
perpendicular to the antigen lanes and incubated at room
temperature for 1 h. After washing to remove nonbound anti-
body, the membrane was incubated with goat anti-human
IgG peroxidase-conjugated antibody (Fab fragment; Boeh-
ringer Mannheim, now Roche, Indianapolis, IN) diluted
1:60,000 for1 h. Positive reactionsweredetected withenhanced
chemiluminescence, by using the ECL Western blotting de-
tection reagents (ECL Western, Amersham Life Sciences) and
the Lumi-Imager workstation (Boehringer-Mannheim). Anti-
body concentrations were estimated by comparing the signal
intensity of unknown samples (subject sera) with those gen-
erated by the known concentrations of human IgG, captured
on the same membrane, by using the LumiAnalyst software.
The detection limit of the assay is *20 ng=ml.
Periodontal organisms selected were representatives from
clusters of organisms reported to be associated with peri-
odontal infection and health by Socransky et al. (59). Subjects
with periodontitis are known to have elevated serum anti-
body levels to periodontal organisms involved with the active
infection. For example, patients with P. gingivalis–associated
periodontitis characteristically display high serum IgG anti-
body titers to cell-wall LPS from this organism (17). Summation
scores for total titers were made by summing IgG concentra-
tions for each of the organisms assayed.
Covariates
Participants were defined as never smokers, former
smokers, or current smokers by interview. The former and
current categories were further divided into light or heavy
smokers, with light smokers reporting more than none but
<20 pack-years of smoking, and heavy smokers reporting
20 pack-years of smoking. This scheme resulted in a five-
level categorization of smoking that simultaneously takes into
account both temporality and magnitude of smoking status as
an exposure. Education was divided into basic (<12 years),
intermediate (12–16 years), or advanced (17–21 years), and
was included to control for socioeconomic status. Age in years
at visit 4 was included, and a variable representing race=
ethnicity (African-American or White) and ARIC center was
designed to control for the ethnic, regional, and examiner
differences in the ARIC cohort. Persons who were not African-
American or White and the few African-Americans in the
Maryland and Minneapolis centers were excluded from
analysis because of small numbers.
Participants fasted for 12 h before the clinical examination,
and blood was collected for plasma lipids including high-
density lipoprotein cholesterol (HDLC), low-density lipo-
protein cholesterol (LDLC), and triglycerides, and for serum
glucose. Diabetes mellitus was defined as fasting serum glu-
cose of 126 mg=dl, 200 mg=dl if nonfasting, or pharmaco-
logic treatment for diabetes, or being told by a doctor one has
diabetes or sugar in the blood (self-reported).
Statistical analysis
Statistical analyses and data management were performed
by using SAS (4); statistical significance was set at p 0.05,
and the unit of analysis was the person. Frequency distribu-
tions, means, empiric distribution functions, and standard
errors were determined to describe the data. When distribu-
tions were skewed, log transformations were applied. Bivariate
relations were investigated by using t tests for continuous
variables and Cochran Mantel-Haenszel w2 statistics and odds
ratios and 95% confidence intervals (CIs) for differences be-
tween categoric variables. Multivariable modeling was per-
formed by using SAS Proc GLM to calculate least-squared
means, adjusting for other study variables. Potential con-
founders were specified a priori, based on the literature as being
associated with either exposure or outcomes. We explored the
effect of infections other than periodontal disease (e.g., sinus,
bronchitis, kidney, and pneumonia) and potential modifiers of
oxidative stress (e.g., arthritis). We included in the analyses
only those effect modifiers or confounders that influence the
association by5%, whether or not they were significant main
effects.
Results
To identify factors related to serum concentrations of
8-isoprostane and total oral biofilm IgG level, pairwise analyses
were conducted for relevant clinical subject-level variables
(Table 1). Serum concentrations of 8-isoprostane were signifi-
cantly higher among older subjects (older than 65 years) and
showed a trend for increased levels among female subjects
( p¼ 0.07). Serum 8-isoprostane levels also varied significantly
by race=center, education, smoking, serum triglycerides, and
extent of probing depth. Serum 8-isoprostane levels decreased
nonsignificantly with increased plaque. Examining the relation
between smoking history and serum 8-isoprostane concentra-
tions (Table 1) shows directional differences, in that current
smokers have lower 8-isoprostane concentrations than former
smokers, heavy smokers have lower 8-isoprostane levels than
light smokers, and current heavy smokers have lower con-
centrations than do nonsmokers; however, never-smokers
have higher 8-isoprostane levels than do current heavy smok-
ers. Mean serum level of total IgG antibody directed to the oral
biofilm was significantly associated with race=center, hyper-
tension, triglycerides, extent of probing depth, plaque, and
serum 8-isoprostane. The association between total IgG and
BMI demonstrated a trend and approached statistical signifi-
cance ( p¼ 0.06). A greater oral bacterial burden was associated
with a significant but modest increase (i.e., 19% increase) in the
level of total IgG, as was more-severe periodontal disease (i.e.,
extent of PD, 5 mm; 12% increase). By comparison, the im-
pact of oxidative stress on the IgG level was marked with a
44% reduction in titer, comparing the highest quartile of
8-isoprostane with the lowest quartile. This suggests that the
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oxidative-stress status of the subject has a greater influence on
the serum IgG titer than does either the level of oral bacteria
present or the presence of periodontal disease, as shown by the
increased extent of probing depths of 5 mm or greater, which
would reflect a greater oral surface area adjacent to the biofilm.
The influence of high oral bacterial burden on serum levels
of IgG antibodies and the modification by oxidative stress are
shown in multivariate models in Table 2. This table demon-
strates that for each plaque group shown in columns Low PI
and High PI, the effect of oxidative stress significantly atten-
uates the IgG antibody titer with significant differences be-
tween IgG titers defined by the quartiles of 8-isoprostane
( p< 0.0001). However, the effects of increased bacterial load
on titer are statistically significant only for the lowest quartile
Table 1. Association of Subject Characteristics with Serum 8-Isoprostane
and Total Oral Biofilm IgG Antibody Levels
Median log 8-isoprostane Mean total biofilm IgG antibody
Group N
Median log 8-isoprostane
(ng=ml) (interquartile range) p Value
Mean total biofilm
IgG level (ng=ml) (SE) p Value
Age <65 yr 3,039 3.66 (1.23–5.75) 1,203.7 (26.7)
65þ yr 1,678 3.93 (2.45–6.00) 0.0060 1,190.0 (35.8) 0.76
Sex Female 2,643 3.83 (1.23–6.00) 1,168.8 (29.1)
Male 2,074 3.67 (1.23–5.75) 0.0710 1,236.7 (31.5) 0.11
Race=field center Jackson Co 689 3.14 (2.56–4.42) 1,533.2 (55.0)
NC, blacks 117 3.79 (1.23–5.38) 1,788.9 (134.1)
NC, whites 1,338 3.59 (2.62–5.67) 1,121.8 (39.4)
Wash Co 1,339 3.48 (1.23–5.59) 1,075.7 (40.1)
Minnesota 1,234 4.71 (2.78–6.00) <0.0001 1,168.4 (41.9) <0.0001
Years of education <11 yr 631 3.50 (2.15–0.30) 1,252.2 (58.4)
12–16 yr 2,065 3.78 (1.23–6.00) 1,185.6 (32.3)
>16 yr 2,017 3.83 (1.58–6.00) 0.0476 1,196.4 (32.7) 0.60
Income ($) <25 K 1,112 3.72 (2.11–5.73) 1,222.2 (43.6)
25 K 50 K 1,669 3.82 (1.23–5.81) 1,211.2 (35.5)
50 Kþ 1,759 3.79 (1.23–6.00) 0.6532 1,153.9 (34.8) 0.37
Smoking Never 2,216 3.74 (1.23–5.77) 1,201.5 (31.3)
Former light 997 3.99 (2.18–6.00) 1,198.2 (46.7)
Former heavy 787 3.86 (2.52–6.00) 1,216.8 (52.1)
Current light 110 3.82 (2.69–6.00) 1,219.9 (139.5)
Current heavy 421 3.57 (1.23–5.69) 0.0461 1,089.4 (71.4) 0.66
BMI <25 1,256 3.59 (1.23–5.71) 1,121.3 (41.4)
25 30 1,918 3.76 (1.72–6.00) 1,194.4 (33.5)
30 35 1,017 3.88 (2.06–6.00) 1,237.6 (45.9)
35þ 518 3.74 (2.61–5.73) 0.1528 1,314.2 (64.4) 0.06
Diabetes No 4,038 3.74 (1.23–5.98) 1,193.7 (23.0)
Yes 666 3.82 (2.54–5.86) 0.4516 1,216.2 (57.6) 0.71
Hypertension No 3,108 3.73 (1.23–5.81) 1,158.5 (25.1)
Yes 1,585 3.80 (2.27–6.00) 0.5102 1,283.8 (40.1) 0.006
LDL Low 2,897 3.78 (1.23–6.00) 1,210.2 (26.9)
High 1,818 3.72 (1.23–5.79) 0.4087 1,178.8 (35.1) 0.48
HDL Low 3,882 3.73 (1.23–5.75) 1,243.6 (48.6)
High 835 3.94 (2.57–6.00) 0.2344 1,189.1 (23.8) 0.33
Triglycerides Low 2,715 3.50 (1.23–5.41) 1,257.3 (29.8)
High 2,002 4.16 (2.66–6.00) <0.0001 1,119.5 (30.0) 0.001
Extent probing depth Low PD 3,521 3.67 (1.23–6.00) 1,167.3 (23.7)
High PD 1,149 3.88 (1.84–5.74) 0.0382 1,312.4 (48.5) 0.004
Plaque Low PI 3,346 3.81 (1.23–6.00) 1,159.3 (24.8)
High PI 1,118 3.66 (2.55–5.24) 0.0973 1,377.8 (48.5) <0.0001
Serum 8-isoprostane 1 NA NA 1,540.9 (41.9)
Quartiles 2 NA NA 1,290.9 (41.7)
3 NA NA 1,080.2 (41.9)
4 NA NA 864.3 (43.1) <0.0001
Extent probing depth, the subject quartile rank for number of sites per subject with at least 5 mm of periodontal probing depth; low PD,
extent PD <5 mm Q1–Q3; high PD, extent PD >5 mm Q4; plaque, the subject quartile rank in whole-mouth score for the Loe-Silness plaque
index, PI; low plq, extent PI Q1–Q3; high Plq, extent PI Q4.
For multileveled variables, the p value reflects the Cochran Mantel-Haenszel w2 test.
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of oxidative stress (Q1; p¼ 0.001). As a result, an overall
nonsignificant increase in IgG antibody level ( p¼ 0.10) was
noted comparing Low PI with High PI. A similar trend is
evident in Table 3, which explores the effect of oxidative stress
on the association between antibody titer and the extent of
periodontal disease severity. Again for each periodontal dis-
ease severity group shown in columns Low PD and High PD,
the effect of oxidative stress increasing Q1–4 significantly at-
tenuates the IgG antibody titer ( p< 0.0001). In this case, for
subjects within the lowest quartile of oxidative stress (Q1), as
well as in Q3, more-extensive periodontal disease is associ-
ated with a statistically significant increase in the total IgG to
the oral biofilm (21% with p¼ 0.002 and 19% with p¼ 0.04,
respectively). The increase in IgG in the group with more
severe periodontal disease is significant overall ( p¼ 0.003) in
contrast to the case with plaque.
Table 4 presents similar patterns when considering subjects
who are in the highest quartile for both probing depths
and plaque levels, in that IgG levels decline with increasing
8-isoprostane level for each probing depth=plaque group, and
an overall effect is seen according to probing depth=plaque
group, independent of 8-isoprostane level ( p¼ 0.0007). It also
is interesting to note that the highest IgG levels appear among
subjects with both probing depths and plaque in the highest
quartile who have the lowest oxidative stress levels
( p¼ 0.002). Collectively, these data indicate that the increases
in the oxidative stress level of the subjects from the lowest
quartile of serum 8-isoprostane (referent group) serve to de-
crease strongly the total IgG response to the commensal oral
biofilm relative to the lesser impact of the biofilm load and the
presence of periodontal disease, both of which tend to in-
crease the total IgG titer. However, not all organisms within
the plaque are invasive pathogens associated with periodon-
tal disease and systemic exposure, and the specificity of IgG
response is explored in Table 5.
The level of total IgG stratified by quartile of 8-isoprostane
is shown adjusted for race=center, age, gender, BMI, smoking,
education, income, diabetes, hypertension, HDLc, LDLc, tri-
glycerides, pocket depth, and oral plaque level in Table 5. This
table includes the key primary periodontal pathogens [P.
gingivalis, T. denticola, and T. forsythensis, the Socransky Red
cluster (56)], and the Orange cluster of pathogens [P. intermedia,
P. nigrescens, C. rectus, F. nucleatum, and P. micra] associated
with less-severe disease as well as A. actinomycetemcomitans.
Other organisms associated with health also are included. As in
Table 1, the total IgG level significantly decreases with in-
creasing oxidative stress, even adjusting for relevant covariates.
The highest quartile of oxidative stress demonstrates a signif-
icant suppression of total IgG as compared with all three lower
quartiles. It can be seen across this table that for the major
pathogenic organisms of the Red Cluster, Orange Cluster, and
A. actinomycetemcomitans, a consistent trend was found for the
lowest IgG titer being seen in the highest quartile of oxidative
stress. The pattern is also present for the remaining biofilm
inhabitants including those associated with health. The results
(Table 5) demonstrate that increased serum 8-isoprostane
concentrations are associated with decreased serum levels of
all 17 antibodies. The serum levels of the respective antibodies
differed somewhat in apparent susceptibility to increasing
serum 8-isoprostane concentrations, with the serum levels of
IgG antibodies for P. gingivalis, P. intermedia, P. nigrescens,
P. micra, S. intermedius, S. oralis, S. sanguis, and S. noxia,
Table 2. Adjusteda Mean Total IgG by Extent Plaque
Index Stratified by Quartile of Serum 8-Isoprostane
Mean total IgG (ng=ml) (SE)
Serum quartiles of
Mean (std err)
8-isoprostaneb (n) Low PI High PI p>|t|a
1 (1,019) 1,515.2 (51.3) 1,806.8 (98.1) 0.001
2 (1,048) 1,311.3 (52.6) 1,305.2 (89.5) 0.95
3 (1,033) 1,043.9 (52.9) 1,157.0 (88.5) 0.29
4 (980) 845.6 (51.8) 906.6 (102.9) 0.60
All (4,080) 1,184.7 (27.2) 1,289.2 (53.1) 0.10
aAdjusted for race=center (five-level), gender, BMI, age, smoking
(five-level), diabetes, hypertension, education (three-level), income
(three-level), probing depth, and serum LDL, HDL, and triglycerides.
b8-Isoprostane effect on IgG significant for both Low-PI and High-
PI groups at p< 0.0001.
Table 3. Adjusteda Mean Total IgG by Extent
of Periodontal Disease (using Extent PD 5 mm)
Stratified by Quartile of Serum 8-Isoprostane
Mean total IgG (ng=ml) (SE)
Serum quartiles of
Mean (std err)
8-isoprostaneb (n) Low PD High PD p>|t|a
1 (1,019) 1,475.1 (49.1) 1,791.5 (88.3) 0.002
2 (1,048) 1,270.9 (49.1) 1,337.3 (89.9) 0.51
3 (1,033) 1,005.1 (50.4) 1,201.1 (80.7) 0.04
4 (980) 852.2 (51.0) 923.7 (90.3) 0.49
All (4,080) 1,169.3 (25.7) 1,335.8 (47.2) 0.003
aAdjusted for race=center, gender, BMI, age, smoking, diabetes,
hypertension, education, income, plaque, and serum LDL, HDL, and
triglycerides.
b8-Isoprostane effect on IgG significant for both High PD and Low
PD groups at p< 0.0001.
Table 4. Adjusteda Mean Total IgG by Both Extent
of Periodontal Disease (using Extent PD 5 mm)
and by Extent Plaque Index Stratified by Quartile
of Serum 8-Isoprostane








1 (1,019) 1,458.1 (58.2) 2,309.6 (185.6) 0.002
2 (1,048) 1,297.4 (58.5) 1,310.6 (149.4) 0.93
3 (1,033) 993.5 (60.2) 1,259.8 (134.3) 0.08
4 (980) 849.3 (58.6) 970.8 (177.5) 0.19
All (4,080) 1,147.0 (30.7) 1,465.4 (84.9) 0.0007
aAdjusted for race=center, gender, BMI, age, smoking, diabetes,
hypertension, education, income, plaque, and serum LDL, HDL, and
triglycerides.
b8-Isoprostane effect on IgG significant for both High PD and Low
PD groups at p< 0.0001.
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showing the largest magnitudes of reduction between the first
and last quartiles of serum 8-isoprostane. Thus, the suppres-
sion of IgG that is associated with high oxidative stress does not
appear to be limited to any specific pathogenic or beneficial
organisms present within the biofilm. Rather, the suppression
of the IgG response was apparent across all the bacterial species
evaluated, including bacteria within human plaque associated
with periodontal health and disease. A similar analysis strati-
fying on periodontal status showed similar results (data
not shown). These data clearly demonstrate that higher oxi-
dative stress is strongly associated with a decrease in the IgG
antibody response to the microbes within the subgingival
biofilm and that the magnitude of the microbial burden and the
presence of periodontal disease are, by comparison, minor
modifiers of serum IgG antibody responses to the commensal
oral biofilm.
Discussion
The findings indicate that higher serum 8-isoprostane
concentrations are related to significantly decreased levels of
serum IgG antibodies against the commensal oral flora. Al-
though these titers reflect whole-bacterial titers, a high degree
of specificity occurs in organism-specific IgG without sig-
nificant cross-reactivity across various microbes under the
stringency conditions of the immunobinding (57). Thus, the
effect of oxidative stress on IgG responses appears to reflect a
suppression of IgG across a wide range of potential antigenic
stimuli. Characterization of the immunodominant antigens
of each bacterium tested, as well as measurements of IgG
subclass responses, was beyond the scope of this molecular
epidemiologic survey of 4,717 subjects. Nonetheless, the lit-
erature suggests that the immunodominant antigens for this
wide range of bacteria include lipopolysaccharides, s-layer
proteins, flagella, OMPs, and extracellular capsules (see, for
example, 50). Thus, the suppression in IgG antibodies seen in
the presence of high oxidative stress does not appear to be
limited to specific biochemical subsets of antigens.
Variables related to serum 8-isoprostane
8-Isoprostane is a stable product of the oxidative metabo-
lism of arachidonic acid (56), and 8-isoprostane concentra-
tions in serum and urine have been used as markers of
systemic oxidative stress (56) and are related to the accumu-
lation of oxidized-LDL (39). The serum concentration of
8-isoprostane has been reported to be related to body mass
index and race (8). In our study, serum 8-isoprostane con-
centrations were related to age, education, smoking, triglyc-
eride levels, and race=center, but not to BMI. Because serum
8-isoprostane concentrations reflect whole-body lipid oxida-
tion, including enzymatic and nonspecific free-radical lipid
oxidative pathways, it appears likely that these variables
and physiologic or pathologic factors (or both) that influ-
ence oxidative lipid metabolism contributed to the serum
8-isoprostane concentrations in our study sample.
Table 5. Adjusted Serum IgG Antibody Levels for Total and Individual Oral Biofilm Bacteria
According to Quartiles of Serum 8-Isoprostane
Mean (SE) serum IgG antibody
levels (ng=ml) by quartiles of serum 8-isoprostane
p Values for indicated comparison
of 8-isoprostane quartiles
IgG antibody specificity (n) 1 2 3 4 Q1 vs. Q4 Q2 vs. Q4 Q3 vs. Q4
Total biofilm IgG (4,080) 1.584 (45) 1,313 (44) 1,068 (44) 871 (46) <0.0001 <0.0001 0.002
P. gingivalis (4,230) 117.2 (7.8) 69.0 (7.9) 72.8 (7.8) 56.1 (7.9) <0.0001 0.24 0.13
T. forsythensis (4,107) 49.0 (2.3) 48.2 (2.3) 39.9 (2.3) 36.3 (2.4) 0.0002 0.0005 0.28
T. denticola (4,229) 38.2 (1.3) 37.6 (1.3) 30.2 (1.3) 23.3 (1.4) <0.0001 <0.0001 0.0003
Total Red biofilm
IgG (4,106)
205.9 (9.7) 155.2 (9.7) 144.6 (9.6) 116.7 (10.0) <0.0001 0.006 0.04
P. intermedia (4,230) 122.2 (4.7) 90.2 (4.7) 71.9 (4.6) 59.6 (4.7) <0.0001 <0.0001 0.06
P. nigrescens (4,230) 214.1 (7.3) 162.1 (7.3) 120.2 (7.3) 88.6 (7.3) <0.0001 <0.0001 0.002
C. rectus (4,230) 38.8 (2.0) 36.9 (2.0) 29.9 (2.0) 27.5 (2.0) <0.0001 0.001 0.41
F. nucleatum (4,213) 19.8 (1.1) 22.6 (1.1) 13.8 (1.1) 13.3 (1.1) <0.0001 <0.0001 0.76
P. micra (4,230) 112.9 (5.3) 120.7 (5.3) 93.5 (5.3) 85.1 (5.3) 0.0003 <0.0001 0.27
Total Orange biofilm
IgG (4,213)
512.1 (15.5) 432.5 (15.5) 329.2 (15.3) 274.1 (15.5) <0.0001 <0.0001 0.01
A. actinomycetemcomitans
(4,230)
163.7 (6.6) 174.9 (6.7) 123.5 (6.7) 111.4 (6.7) <0.0001 <0.0001 0.20
E. corrodens (4,220) 19.0 (1.4) 25.9 (1.4) 16.3 (1.4) 15.7 (1.4) 0.09 <0.0001 0.75
C. ochracea (4,230) 40.2 (1.7) 39.7 (1.7) 29.9 (1.7) 27.4 (1.7) <0.0001 <0.0001 0.30
V. parvula (4,230) 16.2 (1.0) 14.3 (1.0) 11.0 (1.0) 9.7 (1.0) <0.0001 0.001 0.34
S. intermedius (4,230) 133.8 (8.3) 103.3 (8.3) 106.2 (8.2) 77.6 (8.3) <0.0001 0.03 0.01
S. oralis (4,230) 107.8 (5.9) 96.7 (5.9) 54.5 (5.9) 35.6 (6.0) <0.0001 <0.0001 0.02
S. sanguis (4,230) 94.6 (5.8) 77.7 (5.8) 84.8 (5.7) 58.1 (5.8) <0.0001 0.02 0.001
S. noxia (4,230) 168.8 (10.3) 87.2 (10.3) 65.7 (10.2) 46.3 (10.4) <0.0001 0.006 0.18
A. viscosus (4,221) 100.9 (6.8) 98.0 (6.8) 88.6 (6.8) 76.4 (6.8) 0.01 0.03 0.21
Other biofilm IgG (4,211) 748.8 (25.0) 619.5 (25.0) 491.9 (24.8) 381.8 (25.1) <0.0001 <0.0001 0.002
Adjusted for race=center, age, gender, BMI, smoking, education, income, diabetes, hypertension, HDL, LDL, triglycerides, pocket depth,
and oral plaque level.
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Our findings further indicate that an increased preva-
lence of deep probing depths (periodontal disease) is as-
sociated with increased (1.6-fold) serum concentrations of
8-isoprostane (Table 1). The reasons for this association are
not known. However, the epithelium lining of the periodontal
pocket is adjacent to the subgingival biofilm and is structur-
ally unique without tight junctions or keratin. Even in health,
the epithelial attachment to the teeth is a site that has a nat-
ural IL-8 chemotactic gradient, which brings neutrophils
into the periodontal pocket such that they flush around
the teeth and appear in the saliva. Activated neutrophils
within the crevice and saliva may serve to increase salivary
8-isoprostane, as recently reported by Wolfram (63). Thus, the
periodontal tissues may represent a source of systemic oxi-
dative stress because of the presence of high numbers of
activated neutrophils. It is known that the presence of peri-
odontitis is associated with lower serum concentrations of
vitamin C (12), even after adjusting for smoking, suggesting
that periodontal disease may pose an oxidative stress that
consumes ascorbate. Also, the mucosal tissue wounding as-
sociated with deep periodontal pockets has been associated
with an increased occurrence of bacteremia (38). In this regard,
8-isoprostane concentrations have been demonstrated to be
increased in Helicobacter pylori (H. pylori)-positive subjects
(16), noncirrhotic chronic hepatitis C patients (30) and cystic
fibrosis patients (15), as well as animal models of endotoxemia
(3). Because the presence of periodontitis can result in recur-
ring systemic exposure to oral biofilm microorganisms (38), it
is conceivable that the resulting low-level bacteremia, en-
dotoxemia, and consequent metabolic stress could contribute
to an elevated serum concentration of serum 8-isoprostane.
Serum 8-isoprostane related to serum
IgG antibody levels
Our findings demonstrate that serum concentrations of
8-isoprostane above the median or the top quartile, or both,
are related to decreased levels of serum IgG antibodies to a
panel of oral bacteria. These findings were controlled for
smoking status and other known contributors to oxidative
stress (e.g., diabetes, age, BMI, and blood lipids) and peri-
odontal severity (e.g., smoking, age, BMI, and education). To
our knowledge, these findings represent the first demonstra-
tion of an association between serum 8-isoprostane concen-
trations and serum IgG antibody levels to mucosal microbes.
Thus, this investigation demonstrates that systemic oxidative
stress consistently suppresses serum IgG antibody responses
to a comprehensive panel of naturally occurring mucosal
biofilm microbes in a large, representative community-
dwelling population.
Extremes of oxidative stress have been related to changes in
a variety of immune-response mechanisms (28); however, our
findings for the ARIC panel indicate that differences in serum
8-isoprostane concentrations across quartiles of 8-isoprostane
can be related to significant differences in serum antibody
levels for oral bacteria, showing a statistically significant
dose–response relation. The bacteria in our panel of anti-
bodies included gram-negative and -positive bacteria, strict
anaerobes, aerobes, and facultative anaerobes, as well as
species associated with periodontal disease and oral health
(59). Because serum 8-isoprostane concentrations in the top
quartile are related to decreased levels of all members of the
antibody panel, this is not a narrow phenomenon pertaining
to selected bacterial species; nor is it limited to pathogenic or
invasive bacteria. These findings suggest that physiologic
increases in serum 8-isoprostane concentration are associated
with marked attenuation of serum IgG antibody responses to
many species of oral bacteria for large segments of the adult
population. One limitation of this analysis, however, is that
we have not assessed whether the apparent decrease in titer is
due to differences in IgG avidity for oral organisms.
It could be hypothesized that infiltrating neutrophils or
macrophages, or both, capable of mounting an oxidative burst
might control the periodontal microflora and thereby limit
consequent serum IgG antibody responses, leading to an in-
verse relation between serum 8-isoprostane and IgG antibody
levels. For a number of reasons, it is apparent that this is not
the case. An increased presence of periodontal pockets of PD
larger than 5 mm would provide a greater reservoir of acti-
vated periodontal PMNs and macrophages and was associ-
ated here with increased serum 8-isoprostane levels; however,
the greater number of deeper pockets also were associated
with significant increases in levels of serum IgG antibodies.
Increased extent PD >5 mm appeared to have a smaller im-
pact on serum 8-isoprostane levels than did serum triglycer-
ides, education, race=center, or age. Also, suppression was not
exclusive to IgG antibodies directed to bacteria associated
with periodontal disease or bacterial species (e.g., strict an-
aerobes) highly susceptible to the effects of oxidative stress.
Rather, increased serum 8-isoprostane was associated with
marked reductions in serum levels of IgG antibodies to plaque
bacteria associated with periodontal health (e.g., S. sanguis),
which are adept at aerobic growth, and quartiles of increasing
serum 8-isoprostane were associated with suppression of IgG
antibody levels in subjects with both high and low levels of
plaque or PD or both. The ability to mount an oxidative burst
by neutrophils=macrophages is common in the adult popu-
lation (41) and is not likely to distinguish among quartiles of
serum 8-isoprostane levels in a broad population or of the
observed association of serum 8-isoprostane with the sup-
pression of IgG antibody responses.
In parallel analyses not reported here, we found that
within this same subject population, the serum levels of IgG
antibodies to the gastric bacterium H. pylori also were
decreased significantly across quartiles of increasing serum
8-isoprostane, after controlling for variables related to oxi-
dative stress and periodontal severity. Thus, these findings of
the suppression of systemic IgG antibody responses in asso-
ciation with increased 8-isoprostane levels likely are not un-
ique to oral bacteria, nor is it likely that the suppression was
the consequence of a feedback loop between a control of
plaque microorganisms by an oxidative burst by neutrophils=
macrophages within the periodontal tissues and consequent
systemic antibody responses.
Smoking has been associated with decreased levels of
serum IgG antibodies to oral bacteria (60) and decreased
serum concentrations of the water-soluble antioxidant ascor-
bate (58). Smoking also was a significant contributor to our
bivariate models of serum IgG antibody levels (Table 1).
In several clinical populations, serum 8-isoprostane concen-
trations have been reported to be related to a history of
prolonged heavy smoking (46), but a correlation with smok-
ing history was not observed in other populations (8). Because
smoking has been shown not to be related to decreased serum
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concentrations of the lipid-soluble antioxidant, a-tocopherol
(44), it appears that smoking may have greater effects on
water-soluble markers of oxidative stress than on markers
within the lipid-soluble compartment. For these reasons, we
included smoking history as a covariate in our models (Tables
2–5); however, excluding smoking did not have a signifi-
cant effect on model parameters. In analyses not reported
here among the subset of subjects who were ‘‘never smokers,’’
serum 8-isoprostane levels had the same significant relation to
serum IgG antibody levels as those reported here for the
whole population. Thus, the findings reported here suggest a
possible role for lipid-mediated oxidative stress in modulat-
ing the effects of exposure to the oral biofilm microflora on
serum antibody levels.
The results presented in Tables 2 through 4, although not
from a longitudinal study, suggest that the ability to mount
an increased IgG antibody response to either an increased
plaque biofilm burden (PI) or the extent of periodontal disease
(extent PD greater than 5 mm) is most marked and signifi-
cant among that quartile with the lowest level of serum
8-isoprostane. Conversely, physiologic increases in oxidative
stress in the three upper quartiles suppressed IgG antibody
levels, irrespective of the extent of plaque burden or deep
probing depths.
Psychological stress, infection-induced stress, and chemi-
cally induced oxidative stress have been associated with de-
creased antibody levels in both animal models of infection and
in various human populations (4, 18, 61). Moreover, consid-
erable evidence indicates that redox signaling, oxidative stress,
and cellular antioxidant levels can influence the function of
each of the cell types (antigen-presenting cells, T cells, and B
cells) regulating immunogenicity and their roles in IgG syn-
thesis. Thus, the mechanism of suppression of serum IgG an-
tibody levels reported here conceivably could be due to the
inhibition of the function of any one of those cells or a combi-
nation of such cells or both. At the clinical level, the effects of
oxidative stress appear most readily explained by an inhibition
of Th1 cell function. Antigen-presenting cells (APCs) have a
pivotal role in defining the balance of T-cell responses to either
Th1 or Th2 cytokine profiles. Oxidative stress has been shown
to impair APC signaling to T cells (54), whereas depletion of
intracellular APC glutathione (GSH) was shown to favor ex-
pression of Th2 cytokines (47, 53). Studies on T cell–receptor
signaling (11) and of lymphocytes in HIV=AIDS subjects (28)
suggest that Th1-cell function is more susceptible to oxidative
stress than is Th2-cell function, whereas oxidative stress has
been related to increased Th2-driven responses that were at-
tenuated in vivo with antioxidant interventions (64). Overall, it
appears that oxidative stress is associated with suppression of
Th1-mediated responses and increased Th2-mediated re-
sponses. Recent findings indicate that Nrf2, a redox-sensitive
transcription factor that enhances expression of antioxidant
genes, has an important role in the molecular mechanism
whereby oxidative stress modifies Th1 responses mediated by
APCs (34). In preclinical testing, Nrf2 pathway activation in
dendritic cells enhanced Th1 immunity (34), whereas disrup-
tion of Nrf2 expression promoted prooxidative dendritic cells
that led to increased Th2 responses (62). Other studies sug-
gest a role for Nrf2 in modification of mucosal tissue defenses
(2) in humans. Likely the impact of systemic oxidative stress
on APCs, suppression of Th1 function, and mucosal defenses
depends at least in part on how well signaling and gene ac-
tivation mediated by Nrf2 compensate for effects of oxida-
tive stress.
Understanding the role of oxidative stress in relation to
suppression of Th1-mediated serum IgG responses likely
would include an understanding of the IgG-subclass re-
sponses. The IgG subclasses (i.e., IgG1, IgG2, IgG3, and IgG4
in humans) are produced in response to different classes of
antigens and are differentially expressed as a function of
disease stage (35). The dominant serum IgG subclass response
to oral biofilm is of the IgG2 subclass. In turn, the lower total
IgG titers seen in subjects with elevated 8-isoprostane may be
attributable to decreased levels of IgG2 antibody.
Synthesis of the respective IgG antibody subclasses appear
to be differentially regulated by Th1 and Th2 cytokine re-
sponses (19). IgG2 antibody expression has been demon-
strated to be dependent on Th1 cytokines (33), whereas IgG4
expression is induced by Th2 cytokines (52). The roles of Th1
and Th2 cytokines in IgG1 and IgG3 expression are more
complex (9) and appear to depend on both the type of antigen
and the mode of exposure to the immune system.
Stress and mediators of oxidative stress have been associated
with regulation of isotype-specific and IgG subclass–specific
antibody synthesis. In mice, dietary consumption of oxidized
oil has been shown to increase production of the Th2 cytokine
IL4, as compared with the Th1 cytokine g-interferon and to
increase Th2-dependent IgG subclass levels and IgE antibody
responses to ovalbumin (37). In humans, intense physical
training (22) and chronic psychological stress have been asso-
ciated with decreased salivary IgA levels. Likewise, the increase
in plasma IgG2 levels typically associated with periodontitis
was not observed in smokers (24), suggesting that the oxidative
stress associated with smoking attenuated the IgG2 antibody
responses to oral bacteria. Investigation of the relation of serum
8-isoprostane concentrations to serum levels of specific IgG
antibody subclasses will be an important next step.
Conclusions
Our findings demonstrate that serum IgG antibody re-
sponses to the oral biofilm microflora are suppressed in the
presence of systemic oxidative stress. Additional studies
are needed to clarify the role of IgG subtype and avidity to
these findings. These findings suggest possible studies to ex-
plore the clinical impact of oxidative stress in mucosal disease
progression, in the response to therapy, and in the potential
use of antioxidant therapies as modifiers. To understand the
mechanism for the association of 8-isoprostane concentrations
with decreased IgG antibody levels, it will be necessary to
define better the specific mediators of lipid-based redox sig-
naling, specific cellular and molecular targets, and correla-
tions of IgG subclass antibody levels (and antibody isotypes)
to serum 8-isoprostane concentrations. It is expected that
clinical and mechanistic insights from these investigations
will enable interventions that better target populations and
mechanisms likely to have impact on the systemic diseases
that have been associated with systemic exposure to the
mucosal biofilm microflora (5, 6).
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LDLC¼ low-density lipoprotein cholesterol
LPS¼ lipopolysaccharide
Nrf2¼Nuclear factor erythroid 2
p45-related factor 2
OMP¼ outer membrane protein
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S. intermedius¼ Streptococcus intermedius
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S. oralis¼ Streptococcus oralis
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